About Wacker Chemie
Wacker Chemie is a publicly listed company based in Munchen (Germany) founded in 1914. It operates as a silicones, polymers, and bio-solutions are manufactured for various industries. The company has 16,640 employees. Wacker Chemie has completed 2 acquisitions, including ADL Biopharma and Scil Proteins. Its website wacker.com draws about 155 thousand monthly visits. Wacker Chemie offers products and services including Silicones, Dispersions, and Biotech Services. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Microbial Strains. Its competitors include AMILI, Enduro, BioCina, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Wacker Chemie was founded in 1914 in Munich, Germany, and operates in the chemicals sector. Silicones, polymers, and bio-solutions are produced for applications across multiple industries. A 3D printing process for gum and candies has been developed, utilizing CANDY2GUM technology to enable confectionery production with altered mouthfeel. In 2022, revenues of 8.63 billion and net profit of 1.31 billion were reported.
- Headquarters Munchen, Germany
- Employees 16,640
- Stage Public
- SectorsHealthcare
- Website category Heavy Industry and Engineering · Chemical Industry
- Email••••••••
- Website wacker.com
- Social LinkedIn X
- Legal Name Wacker Chemie Ag
- Annual Revenue$6.45 B (USD)-4.13as on Dec 31, 2025
- Net Profit-$964.79 M (USD)-440.71as on Dec 31, 2025
- EBITDA$466.12 M (USD)-43.66as on Dec 31, 2025
- Latest Funding Round$67.07M (USD), Grant
Nov 2020
- Investors
- Employee Count16,640
- Investments & AcquisitionsADL Biopharma
& 1 more
Associated legal entities of Wacker Chemie
Wacker Chemie is associated with 2 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Wacker Chemie India Private Limited CIN U24117MH2007PTC175211 | Active | 19 Oct 2007 | Mumbai, Maharashtra | ₹537 Cr | 33 | 4 | View details |
| Wacker Metroark Chemicals Private Limited CIN U24119WB1998PTC087722 | Active | 13 Aug 1998 | 24 Parganas, West Bengal | ₹1,731 Cr | 304 | 7 | View details |
Products & Services of Wacker Chemie
Wacker Chemie offers a comprehensive portfolio of products and services, including Silicones, Dispersions, and Biotech Services.
Materials for e-mobility and composites applications
Solutions for industrial coatings and adhesives
Production of plasmid DNA and mRNA therapeutics
Funding Insights of Wacker Chemie
- Total Rounds 2
- Last Round Grant — $67.07M
- First Round $309,848
(May 2020)
- Investors Count 1
All 2 funding rounds of Wacker Chemie with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $67.07M | Grant | – | – | |
| May 2020 | $309,848 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Wacker Chemie
Wacker Chemie has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Wacker Chemie
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Wacker Chemie
The boards of the 2 registered companies of Wacker Chemie currently have 8 directors; the longest-serving is Soumitra Ranjan Mukherjee, appointed in 1998. 24 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Soumitra Ranjan Mukherjee DIN 01113738 | Managing Director | 13 Aug 1998 | 28 yrs 2 mo | Wacker Metroark Chemicals Private Limited |
| Anand Narasimhan Gopaladesikan DIN 02469962 | Managing Director | 01 Jan 2015 | 11 yrs 9 mo | Wacker Chemie India Private Limited |
| Peter Alto Summo DIN 07676654 | Director | 09 Dec 2016 | 9 yrs 10 mo | Wacker Chemie India Private Limited |
| Dipankar Dutta DIN 06711393 | Director | 15 Jul 2021 | 5 yrs 3 mo | Wacker Metroark Chemicals Private Limited |
| Sascha Buechel DIN 07214619 | Director | 10 Dec 2021 | 4 yrs 10 mo | Wacker Chemie India Private Limited, Wacker Metroark Chemicals Private Limited |
| Bidisha Bhattacharjee DIN 09294089 | Whole-time director | 12 May 2022 | 4 yrs 5 mo | Wacker Metroark Chemicals Private Limited |
| Apurba Mondal DIN 09605981 | Whole-time director | 12 May 2022 | 4 yrs 5 mo | Wacker Metroark Chemicals Private Limited |
| Thomas . Koini DIN 10233396 | Director | 01 Jul 2023 | 3 yrs 3 mo | Wacker Metroark Chemicals Private Limited |
People of Wacker Chemie
1 people are tracked at Wacker Chemie (1 in leadership); the tracked headcount is 16,640.
| Name | Role | Group |
|---|---|---|
Christian Hartel | CEO | Leadership |
Complete people profiles for Wacker Chemie
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Wacker Chemie
Wacker Chemie is a publicly listed company on the XETR with ticker symbol WCH in Germany, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date10 Apr 2006
- Listed onFRA: WCH
- Listed entityWacker Chemie AG
- Exchange sectorProcess industries
- ISINDE000WCH8881
- Share price88.15 EUR (-0.06% on the day) · 2026-10-14
- Market capitalisation4,381,598,226.00 EUR
- EPS (diluted, trailing year)-16.16 EUR
- Dividend yield2.87%
- Volume (last session)1,337
Financials of Wacker Chemie
Figures of Wacker Chemie India Private Limited, the primary company behind Wacker Chemie, for FY 2022. Revenue was ₹537 Cr (+500% year on year). Net profit was ₹12.63 Cr (2% margin). Revenue has grown at a compounded annual rate of +147% over three years.
- ₹537 CrRevenue · FY 2022 · +500% YoY
- ₹12.63 CrNet profit · 2% margin
- ₹21.00 CrPaid-up capital
- 33Employees (provident fund records)
- +147%Revenue CAGR, 3 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 5.49B EUR | -821.1M EUR | 396.7M EUR |
| 2024 | 5.72B EUR | 241.0M EUR | 704.1M EUR |
| 2023 | 6.40B EUR | 313.6M EUR | 799.2M EUR |
| 2022 | 8.21B EUR | 1.25B EUR | 1.86B EUR |
| 2021 | 6.21B EUR | 806.9M EUR | 1.46B EUR |
Balance sheet, profit and loss, cash flow and ratios of Wacker Chemie India Private Limited are on its company page.
Detailed financial statements for Wacker Chemie
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wacker Chemie
Wacker Chemie has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ADL Biopharma and Scil Proteins.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
APIs and intermediates are developed and manufactured for pharmaceuticals. | adlbiopharma.com | Leon, Spain | 2014 | May 2023 | $110.18M | |
Unique Affilin-based proteins are generated and optimized for therapeutic applications. | scilproteins.com | Halle, Germany | 1999 | Jun 2014 | •••• |
Complete acquisition details for Wacker Chemie
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Wacker Chemie
6 dated milestones of Wacker Chemie across 109 years, from founding to its latest funding, stage changes and deals.
- Founded Wacker Chemie is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Scil Proteins.
- Funding First funding round of $310K.
- Funding Latest funding round, Grant, of $67.1M.
- Acquisition Acquires ADL Biopharma.
Competitors of Wacker Chemie
Wacker Chemie has 9 listed competitors in our database, 4 of them funded. They include AMILI, Enduro, BioCina, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amili.asia | 2019 | Singapore | $10.5M | – | Gut microbiome insights, analytics, tests, and therapeutics are provided. | |
| enduro.bio | 2019 | Copenhagen, Denmark | $12.42M | 13 | Microbial strains are manufactured by Enduro as a CDMO. | |
| biocina.com | 2018 | Thebarton, Australia | – | – | CDMO offering microbial expression systems-based biologics development and manufacturing services | |
| elesztogenetika.com | 2008 | Budapest, Hungary | – | – | CDMO offers microbial expression systems-based biologics development | |
| xiaozaotech.com | 2016 | Shenzhen, China | $15.51M | – | Offers microbial expression systems-based biologics development and manufacturing services | |
| vibalogics.com | 2007 | Cuxhaven, Germany | – | 89 | CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria | |
| b2i.co.jp | 2020 | Kobe, Japan | – | – | Microorganism-based drugs are manufactured by this CDMO in Japan. | |
| bdibiotech.com | 2014 | Valladolid, Spain | $4.78M | – | Microbial strains for biopharma are developed at BDI Biotech. | |
| microbiome-cdmo.com | 1951 | Aurillac, France | – | – | Live biotherapeutic drugs are developed using microbiota and microbiome science. |
Detailed competitors of Wacker Chemie
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Wacker Chemie
The website of Wacker Chemie (wacker.com) receives about 155.5K visits a month and ranks #279,592 among all websites worldwide, #3,041 in Chemical Industry.
- Monthly visits155.5K
▲ 17.2% vs previous month
- Unique visitors55K
per month
- Global rank#279,592
among all websites
- Category rank#3,041
Heavy Industry and Engineering · Chemical Industry
- Bounce rate36%
- Pages per visit2.8
- Average visit1 min 11 sec
- DevicesDesktop 53% · Mobile 47%
Websites whose visitors overlap most with Wacker Chemie. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
wm-blythe.co.uk | wm-blythe.co.uk | 100% | – | – | – |
zhenrchem.com | zhenrchem.com | 95% | – | – | – |
| evonik.com | 93% | 257.1K | #185,770 | View details | |
| harke.com | 87% | – | #1,841,756 | View details | |
xiameter.com | xiameter.com | 80% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Wacker Chemie
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Wacker Chemie (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Wacker Chemie
Complete news archive for Wacker Chemie
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wacker Chemie
Wacker Chemie was founded in 1914 and raised its 1st funding round 106 years after it was founded.
Wacker Chemie is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Wacker Chemie has 16,640 employees.
Annual revenue of Wacker Chemie is $6.45B as on Dec 31, 2025.
Wacker Chemie was founded in 1914 in Munich, Germany, and operates in the chemicals sector. Silicones, polymers, and bio-solutions are produced for applications across multiple industries. A 3D printing process for gum and candies has been developed, utilizing CANDY2GUM technology to enable confectionery production with altered mouthfeel. In 2022, revenues of 8.63 billion and net profit of 1.31 billion were reported.
Wacker Chemie offers Silicones, Dispersions, and Biotech Services.
Yes, Wacker Chemie is publicly traded on XETR under the ticker symbol WCH.
Wacker Chemie has made 2 acquisitions, including ADL Biopharma, and Scil Proteins.
Wacker Chemie has 1 investor. Key investors include European Union.
Wacker Chemie is associated with 2 legal entities: Wacker Chemie India Private Limited, Wacker Metroark Chemicals Private Limited.
The legal entities of Wacker Chemie currently have 10 directors, including Peter Alto Summo, Anand Narasimhan Gopaladesikan, Sascha Buechel and others.